Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2200057	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Supplementary Application	2022-05-24		Bristol-Myers Squibb Company			view
JXSL2100005	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Import Drug Application	2021-01-09	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company	In Review	2021-01-08	view
JXSL2101027	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Import Drug Application	2021-05-14		Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSL2101097	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Import Drug Application	2021-08-17		Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSL2200046	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Import Drug Application	2022-04-13		Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view